Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Vinorelbine Versus Gemcitabine Versus Gemcitabine and Vinorelbine in Elderly Patients With Stage IIIB-IV Non-Small Cell Lung Cancer

Authors not listed

Istituto Nazionale per lo Studio e la Cura dei Tumori · 1998

Abstract

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Randomized phase III trial to compare the effectiveness of vinorelbine, gemcitabine, or both in treating patients who have stage IIIB or stage IV non-small cell lung cancer.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-19 MST

Cite this

APA
Anonymous. (1998). Vinorelbine Versus Gemcitabine Versus Gemcitabine and Vinorelbine in Elderly Patients With Stage IIIB-IV Non-Small Cell Lung Cancer. <em>Istituto Nazionale per lo Studio e la Cura dei Tumori</em>. https://clinicaltrials.gov/study/NCT00003447
Vancouver
Anonymous. Vinorelbine Versus Gemcitabine Versus Gemcitabine and Vinorelbine in Elderly Patients With Stage IIIB-IV Non-Small Cell Lung Cancer. Istituto Nazionale per lo Studio e la Cura dei Tumori. 1998.
BibTeX
@misc{anon1998Vinore, title = {Vinorelbine Versus Gemcitabine Versus Gemcitabine and Vinorelbine in Elderly Patients With Stage IIIB-IV Non-Small Cell Lung Cancer}, author = {Anonymous}, journal = {Istituto Nazionale per lo Studio e la Cura dei Tumori}, year = {1998}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings